IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 156 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $34,003,000 | -60.3% | 3,370,000 | -47.7% | 4.50% | -74.5% |
Q4 2019 | $85,710,000 | +55.0% | 6,439,541 | 0.0% | 17.66% | +113.7% |
Q3 2019 | $55,283,000 | +2.3% | 6,439,541 | +30.4% | 8.26% | -3.7% |
Q2 2019 | $54,039,000 | -19.1% | 4,939,541 | 0.0% | 8.58% | -20.4% |
Q1 2019 | $66,832,000 | +30.6% | 4,939,541 | 0.0% | 10.78% | +24.2% |
Q4 2018 | $51,174,000 | – | 4,939,541 | – | 8.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |